Waters and Thermo Agree to Integrate UPLC with MS Products
News Mar 07, 2006
Waters Corporation and Thermo Electron Corporation have entered into a collaborative agreement to provide integration and connectivity between the Waters® ACQUITY Ultra Performance LC™ system and Thermo’s full range of mass spectrometers.
These instruments include Thermo’s Finnigan™ TSQ Quantum™, LTQ™ Linear Ion Trap, LTQ FT™ Hybrid Linear Trap/Fourier Transform ICR and LTQ Orbitrap™ hybrid mass spectrometer.
The collaboration is in response to scientists and laboratory technicians in the mass spectrometry community who seek the advantages in certain applications of using UPLC with MS, which includes increased throughput and performance.
These same users also want more unified control and results management software to seamlessly combine these complementary technologies.
"UPLC peaks are narrower and sharper, signal-to-noise ratios are higher, and run times are shorter - which are all key factors in enhancing the performance of virtually any mass spectrometer thus bringing laboratories new levels of efficiency," said Rohit Khanna, Vice President of Worldwide Marketing, Waters Corporation.
"For Waters customers, the seamless combination of UPLC technology with Thermo’s high performance mass spectrometry systems promises to bring laboratories more information per unit of time resulting in greater productivity."
Iain Mylchreest, VP and General Manager of Life Sciences Mass Spectrometry for Thermo adds, "This collaboration continues Thermo’s commitment to provide its customers with advanced technology options to improve overall system performance."
"Since mass spectrometers comprise one of Thermo’s largest and fastest growing product lines, and customers have seen the benefits of UPLC technology in combination with Thermo’s high performance mass spectrometry systems, it makes sense to give customers this front-end choice."
Pre-Filled Syringes & Injectable Drug Devices Europe
Jan 16 - Jan 17, 2019
3rd International Conference and Exhibition on Nanomedicine and Drug Delivery
Mar 13 - Mar 14, 2019